EFFERALGANMED PEDIATRIQUE (paracetamol) - Mild to moderate pain and/or fever

Opinions on drugs - Posted on May 06 2024

Reason for request

Modification of the listing conditions

Summary of opinion

Favourable opinion for maintenance of reimbursement in “the symptomatic treatment of mild to moderate pain and/or fever. This form is RESERVED FOR CHILDREN weighing from 3 to 32 kg (from birth to around 12 years)”.


Clinical Benefit

Substantial

The Committee considers that the clinical benefit of EFFERALGANMED 30 mg/ml oral solution is substantial in the MA indication.


Clinical Added Value

Not applicable

Contact Us

Évaluation des médicaments